Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Lymphoma survivors test 5-Minute breathing workout for heart health

NCT ID NCT05938127

First seen Mar 04, 2026 · Last updated Jun 23, 2026 · Updated 16 times

Summary

This study tested whether a short daily breathing exercise (inspiratory muscle strength training) combined with a personalized exercise plan could improve heart health and fitness in lymphoma survivors. Only one person enrolled before the study was stopped early, so no meaningful conclusions can be drawn. The approach was designed to be quick and easy, using a handheld device for about 5 minutes a day.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NON HODGKIN LYMPHOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Anschutz Health and Wellness

    Aurora, Colorado, 80045, United States

  • University of Colorado Cancer Center

    Aurora, Colorado, 80045, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Inspiratory muscle strength training (IMST) device

What this could lead to

If successful, this approach could offer a quick, easy way to boost heart health and fitness in lymphoma survivors.

What could go wrong

The trial was terminated early with only 1 participant, so results are not reliable. It is unclear if the approach works or is safe for this group.

Conditions

The condition(s) this trial relates to.

Hodgkins lymphoma non-Hodgkin lymphoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.